Edita Food Industries - Summary of Resolutions of the Board of Directors Meeting of the company convened on Tuesday dated 10/10/2023
Giza, 10/10/2023
Edita Food Industries S.A.E. ("the Company") announces that the Board of Directors Meeting of the Company convened on Tuesday, 10/10/2023 and unanimously resolved the following resolutions:
1) Approval of the minutes of the previous Board of Directors Meeting (No. 176) dated on 10/10/2023. |
2) Approval of the sale of machinery and equipment to Edita Frozen Food Industries S.A.E. - with approximately EGP 20,000,000 (twenty million Egyptian pounds) and delegating the Chairman of Board of Directors or any person he authorizes to take all the necessary procedures, determine the final price and sign the final contract of the machinery and equipment.
3) Approval of the proposed dividend distribution report including the distribution of part of the retained earnings appearing in the Company's financial statements of 31 December 2022 which entails distributing to the shareholders an amount equal to EGP 299,700,000 (two hundred ninety-nine million seven hundred thousand Egyptian pounds) by way of cash coupon and decided to present it to the general assembly for its approval in its next meeting.
4) Approval of the calling of the Ordinary General Meeting of the Company to convene and delegating the Chairman of the Company in determining the place and way of convening the meeting and amending the date of meeting -if needed- to consider
5) Approval of the delegation of the Chairman and Managing Director to take the necessary procedures for calling the ordinary general assembly meeting to convene and to include any additional agenda items.
|
-Ends
Contacts
Ms. Menna Shams El Din
Investor Relations and Business Development Director
T: +202 3851 6464 | M: +20 100 1542428 | menna.shamseldin@edita.com.eg
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.